“JPMorgan: These 3 Stocks Could Spike at Least 70% From Current Levels”
June 29, 2021
“Day One Biopharmaceuticals (DAWN)…
Overall, there is broad agreement on Wall Street with Rama’s view, as indicated by the unanimous Strong Buy consensus rating, supported by 4 recent positive reviews. Shares in DAWN are selling for $20.11 and their $37.33 average price target implies a one-year upside potential of ~86%…
Altice USA, Inc. (ATUS)…
What does the rest of the Street think? Looking at the consensus breakdown, opinions from other analysts are more spread out. 5 Buys, 3 Holds and 1 Sell add up to a Moderate Buy consensus. In addition, the $42.33 average price target indicates ~23% upside potential from current levels. ..
Similarweb (SMWB)…
This new digital analytic stock has, in its short time on the public market, picked up 7 reviews from Wall Street’s analysts, with a breakdown of 5 to 2 Buy versus Hold giving the shares a Moderate Buy consensus rating. The stock is selling for $18.34 and the $27.67 average price target implies an upside of 52% for the upcoming year…”
https://finance.yahoo.com/news/jpmorgan-3-stocks-could-spike-201823204.html